GATA3 and urothelial carcinoma: GATA3 expression occurs in 49%–100% of pT2-4 urothelial carcinomas but is also seen in 42%–100% of breast cancers, in salivary gland neoplasms and–less commonly—also in various other tumor types [11, 16–18].